Arcadia Biosciences Announces Cash Proceeds of $6.8 Million from Warrant Exercise
The net proceeds of the offering are estimated to be approximately $6.3 million after deducting placement agent fees and other estimated offering expenses.
- The net proceeds of the offering are estimated to be approximately $6.3 million after deducting placement agent fees and other estimated offering expenses.
- Arcadia expects to use the net proceeds from this offering to pursue a range of near-term inorganic growth opportunities within the company's hemp business unit.
- Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients.
- These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.